Loggers, E. T., Chugh, R., Hartner, L. P., Riedel, R. F., Cho, S., Hyslop, D., … Federman, N. (2024). Monitoring ovarian function in oncology studies: Results and insights from the DeFi phase 3 study of nirogacestat in desmoid tumor. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

Loggers, Elizabeth Trice, Rashmi Chugh, Lee P. Hartner, Richard F. Riedel, Sunny Cho, David Hyslop, Allison Lim, Ana B. Oton, and Noah Federman. “Monitoring ovarian function in oncology studies: Results and insights from the DeFi phase 3 study of nirogacestat in desmoid tumor.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

Loggers ET, Chugh R, Hartner LP, Riedel RF, Cho S, Hyslop D, et al. Monitoring ovarian function in oncology studies: Results and insights from the DeFi phase 3 study of nirogacestat in desmoid tumor. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Loggers, Elizabeth Trice, et al. “Monitoring ovarian function in oncology studies: Results and insights from the DeFi phase 3 study of nirogacestat in desmoid tumor.” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.

Loggers ET, Chugh R, Hartner LP, Riedel RF, Cho S, Hyslop D, Lim A, Oton AB, Federman N. Monitoring ovarian function in oncology studies: Results and insights from the DeFi phase 3 study of nirogacestat in desmoid tumor. JOURNAL OF CLINICAL ONCOLOGY. 2024.